Iowa Administrative Code › Agency 641 - Public Health Department › Chapter 4 - Center for Congenital and Inherited Disorders › Rule 641-4.2 - Definitions

Current through Register Vol. 47, No. 3, July 24, 2024
For the purposes of this chapter, the following definitions
				shall apply:
"Advisory committee"
means the congenital and
				inherited disorders advisory committee (CIDAC).
"Anonymized specimen"
means a specimen that
				cannot be traced back to or linked with the particular individual from whom the
				specimen was obtained.
"Attending health care provider"
means the
				licensed physician, nurse practitioner, certified midwife or physician
				assistant providing care to an infant at birth.
"Birthing facility"
means a private or public
				facility licensed pursuant to Iowa Code chapter 135B that has a licensed
				obstetric unit or is licensed to provide obstetric services.
"Center"
means the center for congenital and
				inherited disorders within the Iowa department of public health.
"Central laboratory"
means the state hygienic
				laboratory (SHL), which is designated as the screening laboratory to perform
				testing and reporting for the Iowa newborn screening and Iowa maternal prenatal
				screening programs.
"Central registry"
means the Iowa registry for
				congenital and inherited disorders (IRCID).
"Consulting physician"
means a physician
				designated by the center for congenital and inherited disorders to interpret
				screen results and provide consultation to a licensed health care
				provider.
"Critical congenital heart disease"
or
"CCHD"
means the presence of one or more specific heart
				lesions: hypoplastic left heart syndrome, pulmonary atresia, tetralogy of
				Fallot, total anomalous pulmonary venous return, transposition of the great
				arteries, tricuspid atresia, and truncus arteriosus.
"Department"
means the Iowa department of
				public health.
"Director"
means the director of the Iowa
				department of public health.
"Discharge"
means a release of an infant from
				a hospital or birth center.
"Early ACCESS"
means Iowa's Individuals with
				Disabilities Education Act (IDEA), Part C, program for infants and toddlers.
				Early ACCESS is a statewide, comprehensive, interagency system of integrated
				early intervention services that supports eligible children and their families
				as defined in 281-Chapter 120.
"Early hearing detection and intervention
				program"
means Iowa's newborn hearing screening and follow-up program
				which ensures that all newborns and toddlers with hearing loss are identified
				as early as possible and provided with timely and appropriate audiological,
				educational and medical intervention and family support.
"Federal recommended uniform screening panel"
means the list of disorders for which the U.S. Department of Health and Human
				Services recommends states screen as part of their state newborn screening
				panels.
"Follow-up program"
means the services
				provided to follow up on an abnormal screening result.
"Guardian"
means a person who is not the
				parent of a minor child, but who has legal authority to make decisions
				regarding life or program issues for the child.
"Health care provider"
means a licensed
				physician, nurse practitioner, certified nurse midwife, registered nurse, or
				physician assistant providing medical care to an individual.
"Iowa maternal prenatal screening program"
or
"IMPSP"
means a program that provides a screening test
				designed to identify women with an increased risk of having a baby with a
				congenital or inherited disorder or women at risk of developing a problem later
				in pregnancy.
"Iowa newborn screening panel"
or
"newborn screening panel"
means the list of disorders for
				which the department screens Iowa newborns.
"Iowa newborn screening program"
or
"INSP"
means a program that provides screening of live-born
				Iowa newborns for the disorders listed on the Iowa newborn screening
				panel.
"Newborn critical congenital heart disease (CCHD)
				screening"
means the screening of newborns for seven targeted heart
				conditions (hypoplastic left heart syndrome, pulmonary atresia, tetralogy of
				Fallot, total anomalous pulmonary venous return, transposition of the great
				arteries, tricuspid atresia, and truncus arteriosus) using pulse oximetry or
				other means to detect blood oxygen saturation levels.
"Primary health care provider"
means a
				licensed physician, physician assistant, nurse practitioner, or certified nurse
				midwife providing ongoing primary medical care to a patient.
"Receiving facility"
means the facility
				receiving an infant from a birthing facility.
"Residual maternal prenatal serum screening
				specimen"
means the portion of the specimen that may be left over
				after all necessary activities of the Iowa maternal prenatal screening program
				are completed.
"Residual newborn screening specimen"
means
				the portion of the dried blood spot specimen that may be left over after all
				activities necessary for the Iowa newborn screening program are
				completed.
"Specialty genetics provider"
means a medical
				geneticist, genetic nurse, or genetic counselor.
"State hygienic laboratory"
or
"SHL"
means the designated central testing laboratory.
"Transferring facility"
means the birthing
				facility that transfers the infant to another facility.